🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT06745362
Active, not recruiting Not applicable

Weight Reduction With the Low-Insulin-Method - Self Monitoring of Breath Acetone

NCT06745362 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2025-01-01
Last updated
2026-08-10

Condition(s) studied

Overweight and Obese Volunteers

Investigational drug(s) / intervention(s)

self-monitoring of breath acetonelifestyle-intervention via LIM-App

self-monitoring of breath acetone: Participants perform self-monitoring of braeth acetone in order to get information about their ketosis state.

lifestyle-intervention via LIM-App: Participants are offered a lifestyle intervention via LIM-App.

Study summary

The goal of this clinical trial is to learn if lifestyle intervention with information about ketosis state supports weight reduction in overweight adults.

Researchers will compare an App-based lifestyle intervention with self-monitoring of breath acetone vs. lifestyle intervention alone.

Participants will:

Get a lifestyle intervention via the LIM-App for 12 months. Report body weight.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Body Mass Index \> 25kg/m2 Exclusion Criteria: \-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
West German Center of Diabetes and Health Düsseldorf Germany

More West German Center of Diabetes and Health trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06745362 on ClinicalTrials.gov ↗ ← All trials in Germany